- Lobbying
- pharmaceutical AND care AND management
Lobbying Arrangements Results for 'Pharmaceutical Care Management'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details PBM Oversight. |
Bluestone Strategies (on behalf of Pharmaceutical Care Management Association)
|
Welsh Rose, LLC | |||
Details Medicare Part D regulations. |
Pharmaceutical Care Management Association
|
Manatt, Phelps, and Phillips | |||
Details Issues related to the pharmaceutical industry Issues related to the pharmaceutical drug supply chain Issues related to pharmaceutical drug pricing Issues related to federal drug supply chain regul... |
Pharmaceutical Care Management Association
|
BOCKORNY GROUP, INC. | |||
Details Medication Therapy Management |
Omnicare, Inc.
Pharmaceutical care for seniors |
Blank Rome Government Relations LLC | |||
Details Federal Trade Commission - antitrust issues related to PBMs FTC inquiry into competitive market for PBMs |
The Pharmaceutical Care Management Association
|
Bose Public Affairs Group | |||
Details Issues relating to the design of Medicare Part D and Part B reimbursement of drugs and biologics in the Inflation Reduction Act. |
Pharmaceutical Research and Manufacturers of America
|
Federal Health Counsel, LLC | |||
Details Federal Trade Commission oversight of Pharmacy Benefit Managers |
Pharmaceutical Care Management Association
|
Quadripoint Strategies LLC | |||
Details Issues regarding Prescription Benefit Managers, specifically on legislation affecting Prescription Benefit Managers being included in a spending package. |
Pharmaceutical Care Management Association
|
COLAS & ASSOCIATES, LLC | |||
Details H.R.3590 - Patient Protection and Affordable Care Act and H.R.4872 - Health Care and Education Reconciliation Act of 2010 - Transparency, industry tax, biogenics, Federal Employee health plan. H.R.... |
Pharmaceutical Care Management Association
|
BelleAire Consulting | |||
Details Issues relating to pharmacy benefit managers |
Pharmaceutical Care Management Association
National association representing pharmacy benefit managers |
Emergent Strategies | |||
Details medication therapy management legislation,particulary HR 1024 and S 557 |
Horizon Government Affairs
|
Mr. John Coster | |||
Details Medicare, Medicaid, General Healthcare, Patient Protection and Affordable Care Act (PL 111-148) Implementation |
Silverlink Communications Inc.
Healthcare |
Bluestone Strategies LLC | |||
Details Track and monitor Internet Pharmacy Issues. HR 3590, Patient Protection and Affordable Care Act. Track and monitor. HR 3962, Affordable Health Care for America Act. Track and monitor. S. 525, Pha... |
Phoenix Capital Management, LLC
|
WALKER, MARTIN & HATCH, LLC | |||
Details Medicare issues. Medicaid issues. S.1190 the Ensuring Seniors Access to Local Pharmacies Act of 2015. Health care issues. |
Pharmaceutical Care Management Association
|
Hayes Health Policy Strategies, PLLC | |||
Details Competition issues in the pharmacy benefit management industry. |
Pharmaceutical Care Management Association
|
The Gibson Group, LLC | |||
Details Pharmaceutical Manufacturing; Pharmacy Issues; Medicare Prescription Drug Benefits; Amendments to the Social Security Act relating to prescription drugs, chemotherapy, and cardiology care; Any legi... |
New Century Health (f/k/a New Century Infusion Solutions)
|
DUMBARTON GROUP & ASSOCIATES, LLC | |||
Details Issues related to the pharmaceutical industry Issues related to Medicare Part B and Part D |
EMD Serono, Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details HR 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 (PATIENT Act), advocating concerns over additional reporting requirements regarding PBMs. HR 4822, H... |
Pharmaceutical Care Management Association
|
RYAN COSTELLO STRATEGIES | |||
Details Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, sci... |
Pharmaceutical Care Management Association
|
Jennings Policy Strategies | |||
Details issues related to pharmaceutical drugs |
BioDelivery Sciences International
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Fiscal Year 2007 and Fiscal Year 2008 appropriations and Native American Housing and Self Determination Act reathorization. |
Southern Plain Indian Housing Association
Represents Indian Housing Authorities |
DUTKO WORLDWIDE, LLC | |||
Details Gaining support for H.R. 2404/S.1509 Treat and Reduce Obesity Act in the House and Senate. Asking for Congressional support to allow the Centers for Medicare and Medicaid Services (CMS) to include... |
Vivus Inc.
|
Hooper, Lundy & Bookman, P.C. | |||
Details Monitor legislative developments in health care Monitor for legislative developments in health care |
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)
|
The Glover Park Group LLC | |||
Details Issues relating to the implementation of Medicare Drug Negotiations and the calculation of Medicaid best price. |
AMGEN, INC.
|
Federal Health Counsel, LLC | |||
Details Chronic disease prevention and management within the Senate HELP Committee's "Affordable Health Choices Act," and the Senate Finance Committee's "America's Healthy Futures Act of 2009. Follow-on B... |
PhRMA (on behalf of We Work for Health and Partnership to Fight Chronic Disease)
|
Public Affairs Company | |||
Details H.R. 3561, PATIENT Act of 2023, all provisions. H.R. 4822, Health Care Price Transparency Act, all provisions. H.R. 4507, Transparency Coverage Act, all provisons. H.R. 4508, Hidden Fee Disclosure ... |
Pharmaceutical Care Management Association
|
1607 STRATEGIES, LLC | |||
Details Education regarding the existing Department of Veterans Affairs Pharmaceutical Prime Vendor contract. |
McKesson Corporation
|
ALSTON & BIRD LLP | |||
Details H.R. 3200, America's Affordable Health Choices Act, H.R. 3962, Affordable Health Care for America Act, and H.R. 3590, The Patient Protection & Affordable Health Care Act. |
HOFFMAN-LA ROCHE INC. (ROCHE)
|
THE NICKLES GROUP, LLC | |||
Details FDA related issues; DTC advertizing follow on biologics-(biosimilars); Health care reform issues as they relate to pharmaceutical industry in general and sanofi-aventis in particular Manufacturing ... |
sanofi-aventis U.S. Inc.
|
PrO Unlimited | |||
Details Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives. Medicare payment for inpatient antibiotics. |
Antimicrobial Innovation Alliance
|
THE MCMANUS GROUP | |||
Details H. Res 295 and S. Res 243 - Resolution to promote increased awareness, diagnosis, and treatment of atrial fibrillation, and to address high mortality and morbidity and to reduce hospitalizations. -... |
sanofi-aventis U.S., Inc
Pharmaceutical Company |
Ms. Camille Bonta | |||
Details Improving health and lowering health care costs through prevention and management of chronic disease. |
PhRMA o/b/o Partnership to Fight Chronic Disease formerly o/b/o CAMI & PFCD
|
Policy Breakthroughs LLC | |||
Details Quality improvement and cost containment of health care through prevention and better management of chronic disease; H.R 3590; H.R. 3962 |
PhRMA (on behalf of We Work for Health and Partnership to Fight Chronic Disease)
|
APCO WORLDWIDE INC. | |||
Details Clarification of the orphan drug exclusion in the annual pharmaceutical fee; any and all deficit reduction proposals/policies affecting plasma protein therapies; implementation of the Affordable Ca... |
PLASMA PROTEIN THERAPEUTICS ASSOCIATION
|
Kelley Drye & Warren LLP | |||
Details Issues related to diabetes and cardiovascular disease |
Boehringer Ingelheim Pharmaceuticals, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues relating to the distribution of health care products Issues relating to competitive bidding and pharmaceutical pedigree 21st Century Cures initiative; Medical device licensure legislation |
Health Industry Distributers Association
|
BLANK ROME GOVERNMENT RELATIONS | |||
Details FDA issues Medicare reimbursement issues |
Eagle Pharmaceuticals Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details The Alliance is working to develop consensus proposals to modify the Stark Act, Anti-Kickback Statute (AKS), False Claims Act, and other laws or regulations to establish an environment that encoura... |
Breaking Down Barriers to Payment/Delivery System Reform Alliance
|
Leavitt Partners, LLC | |||
Details Inflation Reduction Act Medicare Part D 6 Protected Classes H.R.5237, The Reduced Cost and Continued Cures Act SMART Prices Act (S. 1264) Lowering Drug Costs for American Families Act (H.R. 4895) E... |
Sumitomo Pharma America, Inc. (formerly Sunovion Pharmaceuticals Inc.)
|
Sumitomo Pharma America, Inc.(formerly Sunovion Pharmaceuticals Inc.) | |||
Details Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Ben... |
Pharmaceutical Care Management Association (PCMA)
|
Bluestone Strategies, LLC | |||
Details S.3686, FY 2011 Appropriations for the Departments of Labor, Health and Human Services, Education and Related Agencies. Specifically for implementation of medication therapy management services pr... |
National Community Pharmacists Association
|
REINECKE STRATEGIC SOLUTIONS, INC. | |||
Details S. 2364 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions related to supply chain risk assessment. The Pandemic and All-Hazards Preparedness Reauthorization Act: Provisions related ... |
The United States Pharmacopeial Convention
|
in-house lobbying | |||
Details issues related to pharmaceutical drugs |
ASTELLAS PHARMA US
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Regulatory and legislative health care issues, including Alzheimers disease drug development Drug Pricing Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) including priority revie... |
Eisai Inc.
|
in-house lobbying | |||
Details Issues pertaining to the self-insurance industry and stop-loss insurance; issues pertaining to captive insurance election under IRC 831 (b) H.R.6201 - Families First Coronavirus Response Act H.R.74... |
Calmetto Management Group (on behalf of Self-Insurance Institute of America Inc)
|
FEROX STRATEGIES | |||
Details Patient access and maintain six protected classes for depressions and schizophrenia under Medicare Part D; Inflation Reduction Act of 2022 implementation Medicaid Drug Rebate Program proposed rule ... |
Alkermes, Inc.
|
in-house lobbying | |||
Details Advocate on behalf of pharmaceutical benefit management practices impacted by direct and indirect remuneration and point of sale rebates related to the Medicare Part D prescription drug benefit pro... |
CVS Caremark
|
The D Major Group | |||
Details Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics ... |
ACADEMY OF MANAGED CARE PHARMACY
|
in-house lobbying | |||
Details Issues related to fertility treatment and coverage for federal employees (no bill); issues related to veteran health care coverage (no bill); H.R. 544, Veterans Infertility Treatment Act (entire bi... |
Ferring Pharmaceuticals
|
in-house lobbying | |||
Details 340B drug discount program; drug pricing; importation of biopharmaceuticals; direct-to-consumer (DTC) advertising; transparency; international pharmaceutical supply chain; antimicrobial resistance ... |
Pharmaceutical Research and Manufacturers of America
|
Crossroads Strategies, LLC |